Skip to Main Content
August 12, 2020

Health Law Daily

Trump Administration Reaches Deal With Moderna To Manufacture, Deliver 100M Doses Of COVID-19 Vaccine

  • August 12, 2020

CNN (8/11, Christensen) reports, “The Trump administration has reached a deal with Moderna Inc. to manufacture and deliver 100 million doses of the company’s Covid-19 vaccine once it is approved, according to a news release from the US Health and Human Services Department.” Under the “contract, worth up to $1.525 billion for 100 million doses, the doses would be owned by the US government and would be distributed and used as part of its Covid-19 vaccine campaign.” CNN adds, “If the doses are used, they would be provided to Americans at no cost.”
      Bloomberg (8/11, Raimonde, Langreth) reports, “Moderna, which is already receiving $955 million in government assistance to test the vaccine, will be selling the vaccine for roughly $15 a dose, or $30 for a two-dose regimen.” Moreover, the company “will manufacture the vaccine as clinical trials continue, according to a statement from” HHS.
      Reuters (8/11, Mason, O'Donnell) reports the US “has advanced purchase agreements with Johnson & Johnson, AstraZeneca Plc, Pfizer Inc and BioNTech SE, and Sanofi SA and GlaxoSmithKline Plc for their respective vaccine candidates.”